Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 72.00
+0.30 (0.42%)
May 29, 2026, 1:30 PM CST
Handa Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 780.8 | 749.77 | 472.74 | 726.89 | -40.01 | -247.67 |
Depreciation & Amortization | 162.68 | 163.83 | 10.16 | 12.15 | 14.82 | 16.49 |
Other Amortization | 0.31 | 0.31 | 0.27 | 0.3 | 0.36 | 18.67 |
Loss (Gain) From Sale of Assets | -12.84 | -12.84 | 0.19 | -4.61 | 0 | -0.02 |
Loss (Gain) on Equity Investments | -2.92 | -0.29 | 1.81 | -2.37 | - | - |
Stock-Based Compensation | 19.09 | 16.39 | 22.39 | 8.47 | 0.11 | 0.26 |
Other Operating Activities | -24.51 | -21.13 | -189.23 | 51.87 | -5.55 | -13.62 |
Change in Accounts Receivable | -656.79 | -762.56 | 207.08 | -226.18 | -140.58 | 13.41 |
Change in Inventory | 45.35 | 39.22 | - | - | 10.11 | - |
Change in Accounts Payable | 54.2 | 47.04 | 6.57 | 8.34 | 5.1 | -8.26 |
Change in Other Net Operating Assets | -6.7 | 23.9 | -34.38 | 93.51 | -55.93 | 41.51 |
Operating Cash Flow | 358.67 | 243.63 | 497.6 | 668.36 | -211.57 | -179.24 |
Operating Cash Flow Growth | 20.73% | -51.04% | -25.55% | - | - | - |
Capital Expenditures | -35.18 | -16.92 | -7.77 | -0.94 | -0.64 | -5.58 |
Sale of Property, Plant & Equipment | - | - | 0 | - | 0 | 0.03 |
Cash Acquisitions | -155.9 | -155.9 | -819.63 | - | - | - |
Divestitures | - | - | - | -10.97 | - | - |
Sale (Purchase) of Intangibles | -0.17 | -0.17 | - | - | -0.12 | -1.57 |
Investment in Securities | -1,518 | -674.86 | 431.12 | -1,653 | 30.71 | 3.98 |
Other Investing Activities | - | - | -0.65 | - | -0.45 | 0.23 |
Investing Cash Flow | -1,709 | -847.84 | -396.92 | -1,665 | 29.5 | -2.91 |
Long-Term Debt Repaid | - | -13.26 | -6.07 | -7.17 | -7.19 | -7.77 |
Total Debt Repaid | -13.19 | -13.26 | -6.07 | -7.17 | -7.19 | -7.77 |
Net Debt Issued (Repaid) | -13.19 | -13.26 | -6.07 | -7.17 | -7.19 | -7.77 |
Issuance of Common Stock | 944.62 | 2,102 | 3.12 | 1,313 | 320.83 | 170.68 |
Repurchase of Common Stock | -203.74 | -57.88 | -56.52 | - | - | - |
Common Dividends Paid | -236.3 | -236.3 | -141.09 | - | - | - |
Other Financing Activities | -3 | -3 | - | - | - | - |
Financing Cash Flow | 488.39 | 1,792 | -200.55 | 1,306 | 313.65 | 162.91 |
Foreign Exchange Rate Adjustments | 26.9 | 22.39 | 30.2 | -8.34 | -28.97 | 2.44 |
Net Cash Flow | -834.84 | 1,210 | -69.67 | 301.13 | 102.6 | -16.81 |
Free Cash Flow | 323.49 | 226.72 | 489.84 | 667.42 | -212.21 | -184.82 |
Free Cash Flow Growth | 12.05% | -53.72% | -26.61% | - | - | - |
Free Cash Flow Margin | 18.40% | 13.11% | 58.97% | 60.33% | -107.35% | -632.19% |
Free Cash Flow Per Share | 2.01 | 1.46 | 3.47 | 4.95 | -1.69 | -1.57 |
Cash Interest Paid | 1.04 | 1.04 | 0.49 | 0.22 | 0.28 | 0.23 |
Cash Income Tax Paid | 191.19 | 191.19 | 197.46 | 7.78 | 2.42 | 0.45 |
Levered Free Cash Flow | 858.39 | 287.3 | 438.42 | 450.86 | -224.91 | -74.36 |
Unlevered Free Cash Flow | 859.65 | 287.95 | 438.73 | 450.99 | -224.74 | -74.21 |
Change in Working Capital | -563.93 | -652.4 | 179.27 | -124.33 | -181.31 | 46.66 |